BRPI0818674A2 - Método para produção de anticorpos - Google Patents

Método para produção de anticorpos

Info

Publication number
BRPI0818674A2
BRPI0818674A2 BRPI0818674-0A2A BRPI0818674A BRPI0818674A2 BR PI0818674 A2 BRPI0818674 A2 BR PI0818674A2 BR PI0818674 A BRPI0818674 A BR PI0818674A BR PI0818674 A2 BRPI0818674 A2 BR PI0818674A2
Authority
BR
Brazil
Prior art keywords
antibody production
antibody
production
Prior art date
Application number
BRPI0818674-0A2A
Other languages
English (en)
Inventor
Yoshiki Yamada
Tatsuya Kiyasu
Kazuyuki Tabata
Akihiro Kuzumaki
Mai Yamashiro
Original Assignee
Chugai Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=40567372&utm_source=***_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BRPI0818674(A2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Chugai Pharmaceutical Co Ltd filed Critical Chugai Pharmaceutical Co Ltd
Publication of BRPI0818674A2 publication Critical patent/BRPI0818674A2/pt
Publication of BRPI0818674B1 publication Critical patent/BRPI0818674B1/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
    • C07K2317/56—Immunoglobulins specific features characterized by immunoglobulin fragments variable (Fv) region, i.e. VH and/or VL
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2510/00—Genetically modified cells
    • C12N2510/02—Cells for production

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
BRPI0818674-0A 2007-10-15 2008-10-14 Métodos para produção de um anticorpo inteiro ou de um fragmento do mesmo e para preparação de fármacos, bem como vetor recombinante BRPI0818674B1 (pt)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
JP2007267384 2007-10-15
JP2007-267384 2007-10-15
JP2008-103308 2008-04-11
JP2008103308 2008-04-11
PCT/JP2008/068588 WO2009051108A1 (ja) 2007-10-15 2008-10-14 抗体の製造方法

Publications (2)

Publication Number Publication Date
BRPI0818674A2 true BRPI0818674A2 (pt) 2014-10-14
BRPI0818674B1 BRPI0818674B1 (pt) 2023-01-17

Family

ID=40567372

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0818674-0A BRPI0818674B1 (pt) 2007-10-15 2008-10-14 Métodos para produção de um anticorpo inteiro ou de um fragmento do mesmo e para preparação de fármacos, bem como vetor recombinante

Country Status (17)

Country Link
US (3) US9683027B2 (pt)
EP (1) EP2202307B2 (pt)
JP (4) JP4976502B2 (pt)
KR (1) KR101558009B1 (pt)
CN (3) CN103540632A (pt)
AU (1) AU2008312937B2 (pt)
BR (1) BRPI0818674B1 (pt)
CA (1) CA2701338C (pt)
DK (1) DK2202307T4 (pt)
ES (1) ES2499391T5 (pt)
IL (2) IL205051A (pt)
MX (1) MX2010004007A (pt)
PL (1) PL2202307T5 (pt)
SG (1) SG185302A1 (pt)
SI (1) SI2202307T2 (pt)
TW (1) TWI463010B (pt)
WO (1) WO2009051108A1 (pt)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9683027B2 (en) * 2007-10-15 2017-06-20 Chugai Seiyaku Kabushiki Kaisha Method for production of antibody
SI2493922T1 (sl) 2009-10-26 2017-06-30 F. Hoffmann-La Roche Ag Postopek za proizvodnjo glikoziliranega imunoglobulina
MX345399B (es) * 2010-12-28 2017-01-30 Chugai Pharmaceutical Co Ltd Metodo de cultivo de celulas animales.
EP2968544A4 (en) * 2013-03-15 2016-10-12 Hoffmann La Roche CELL CULTURE MEDIA AND METHOD FOR PRODUCING ANTIBODY
RU2674996C2 (ru) 2013-07-04 2018-12-14 Ф. Хоффманн-Ля Рош Аг Иммуноферментный анализ с подавлением интерференции для определения антител к лекарствам в образцах сыворотки
US20190225694A1 (en) 2016-06-28 2019-07-25 Zaklady Farmaceutyczne Polpharma Sa Recombinant production of monoclonal antibodies
EP3541413A2 (en) 2016-11-21 2019-09-25 Polpharma Biologics S.A. Aqueous pharmaceutical formulations

Family Cites Families (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8607679D0 (en) 1986-03-27 1986-04-30 Winter G P Recombinant dna product
JPS6459878A (en) 1987-08-31 1989-03-07 Matsushita Electric Ind Co Ltd Semiconductor laser protective circuit
ES2139598T3 (es) 1990-07-10 2000-02-16 Medical Res Council Procedimientos para la produccion de miembros de parejas de union especifica.
GB9015198D0 (en) 1990-07-10 1990-08-29 Brien Caroline J O Binding substance
ES2108048T3 (es) 1990-08-29 1997-12-16 Genpharm Int Produccion y utilizacion de animales inferiores transgenicos capaces de producir anticuerpos heterologos.
JPH06500470A (ja) † 1990-09-04 1994-01-20 メルク　エンド　カンパニー　インコーポレーテッド メチロトローフ酵母細胞におけるインスリン様成長因子の産生
DE69229482T2 (de) † 1991-04-25 1999-11-18 Chugai Pharmaceutical Co Ltd Rekombinierte humane antikörper gegen den humanen interleukin 6-rezeptor
EP0605522B1 (en) 1991-09-23 1999-06-23 Medical Research Council Methods for the production of humanized antibodies
ES2341666T3 (es) 1991-12-02 2010-06-24 Medimmune Limited Produccion de autoanticuerpos de repertorios de segmentos de anticue rpos expresados en la superficie de fagos.
EP0746609A4 (en) 1991-12-17 1997-12-17 Genpharm Int NON-HUMAN TRANSGENIC ANIMALS CAPABLE OF PRODUCING HETEROLOGOUS ANTIBODIES
CA2131151A1 (en) 1992-03-24 1994-09-30 Kevin S. Johnson Methods for producing members of specific binding pairs
AU675661B2 (en) 1992-07-24 1997-02-13 Abgenix, Inc. Generation of xenogeneic antibodies
JPH08509612A (ja) 1993-04-26 1996-10-15 ジェンファーム インターナショナル インコーポレイテッド 異種抗体を産生することができるトランスジェニック非ヒト動物
GB9313509D0 (en) 1993-06-30 1993-08-11 Medical Res Council Chemisynthetic libraries
CA2177367A1 (en) 1993-12-03 1995-06-08 Andrew David Griffiths Recombinant binding proteins and peptides
EP0770628B9 (en) 1994-07-13 2007-02-28 Chugai Seiyaku Kabushiki Kaisha Reconstituted human antibody against human interleukin-8
US5561053A (en) 1994-08-05 1996-10-01 Genentech, Inc. Method for selecting high-expressing host cells
CA2219361C (en) 1995-04-27 2012-02-28 Abgenix, Inc. Human antibodies derived from immunized xenomice
WO1996034096A1 (en) 1995-04-28 1996-10-31 Abgenix, Inc. Human antibodies derived from immunized xenomice
AU8755798A (en) * 1997-04-04 1998-11-13 Biosite Diagnostics Incorporated Polyvalent and polyclonal libraries
US20020062010A1 (en) 1997-05-02 2002-05-23 Genentech, Inc. Method for making multispecific antibodies having heteromultimeric and common components
WO1998050431A2 (en) 1997-05-02 1998-11-12 Genentech, Inc. A method for making multispecific antibodies having heteromultimeric and common components
US6171586B1 (en) * 1997-06-13 2001-01-09 Genentech, Inc. Antibody formulation
AU2002307037B2 (en) † 2001-04-02 2008-08-07 Biogen Idec Inc. Recombinant antibodies coexpressed with GnTIII
US6605176B2 (en) * 2001-07-13 2003-08-12 Taiwan Semiconductor Manufacturing Co., Ltd. Aperture for linear control of vacuum chamber pressure
US20030157641A1 (en) * 2001-11-16 2003-08-21 Idec Pharmaceuticals Corporation Polycistronic expression of antibodies
CN1585822A (zh) * 2001-11-16 2005-02-23 拜奥根Idec公司 抗体的多顺反子表达
EP2204190A1 (en) 2003-07-15 2010-07-07 Chugai Seiyaku Kabushiki Kaisha IgM production by transformed cells and methods for quantifying said IgM production
CN1961071A (zh) * 2004-03-15 2007-05-09 比奥根艾迪克Ma公司 使用可选剪接在真核细胞中表达多肽多聚体的方法和构建物
US7919086B2 (en) * 2004-07-09 2011-04-05 Chugai Seiyaku Kabushiki Kaisha Anti-glypican 3 antibody
GB0425534D0 (en) * 2004-11-19 2004-12-22 Celltech R&D Ltd Process for obtaining antibodies
WO2007014162A2 (en) * 2005-07-21 2007-02-01 Abbott Laboratories Multiple gene expression including sorf constructs and methods with polyproteins, pro-proteins, and proteolysis
US9683027B2 (en) * 2007-10-15 2017-06-20 Chugai Seiyaku Kabushiki Kaisha Method for production of antibody

Also Published As

Publication number Publication date
JP6092304B2 (ja) 2017-03-08
AU2008312937A1 (en) 2009-04-23
EP2202307B2 (en) 2021-07-14
KR101558009B1 (ko) 2015-10-19
JP6506786B2 (ja) 2019-04-24
KR20100074184A (ko) 2010-07-01
US11136375B2 (en) 2021-10-05
PL2202307T5 (pl) 2021-10-04
IL205051A (en) 2015-09-24
JP2015198663A (ja) 2015-11-12
PL2202307T3 (pl) 2015-02-27
IL240122A0 (en) 2015-09-24
ES2499391T3 (es) 2014-09-29
IL205051A0 (en) 2010-11-30
JP5788830B2 (ja) 2015-10-07
MX2010004007A (es) 2010-06-15
US9683027B2 (en) 2017-06-20
BRPI0818674B1 (pt) 2023-01-17
JP2017079794A (ja) 2017-05-18
EP2202307A1 (en) 2010-06-30
CN103540632A (zh) 2014-01-29
DK2202307T3 (da) 2014-09-15
TW200934867A (en) 2009-08-16
JPWO2009051108A1 (ja) 2011-03-03
US20100291627A1 (en) 2010-11-18
US20210300996A1 (en) 2021-09-30
CA2701338A1 (en) 2009-04-23
CN101802192A (zh) 2010-08-11
SI2202307T1 (sl) 2014-11-28
US20170275351A1 (en) 2017-09-28
CA2701338C (en) 2018-09-18
JP2012143246A (ja) 2012-08-02
EP2202307A4 (en) 2012-01-25
JP4976502B2 (ja) 2012-07-18
EP2202307B1 (en) 2014-08-20
SI2202307T2 (sl) 2021-11-30
CN106244651A (zh) 2016-12-21
DK2202307T4 (da) 2021-10-04
IL240122B (en) 2019-02-28
ES2499391T5 (es) 2021-12-22
AU2008312937B2 (en) 2015-01-22
TWI463010B (zh) 2014-12-01
WO2009051108A1 (ja) 2009-04-23
SG185302A1 (en) 2012-11-29

Similar Documents

Publication Publication Date Title
BRPI0917145A2 (pt) Método para fabricar biocombustíveis
BRPI0719843A2 (pt) Método para a produção de bisbenzoxazóis
BRPI0922490A2 (pt) Método para produção de beta-santaleno
BRPI0817836A2 (pt) Método para a produção de cerveja
BRPI0821158A2 (pt) Método para fazer lentes de contato
BRPI0814359A2 (pt) Método
BRPI0817226A2 (pt) Método
BR112012002746A2 (pt) método para produção de copolímero
BRPI0817726A2 (pt) Método
CR10705A (es) Anticuerpos para linfotoxina-alfa
BRPI0819238A2 (pt) Métodos para a produção de caseína
BRPI0819337A2 (pt) Método para produção de glicinatos de acila
BRPI0910454A2 (pt) processo para produção de uma proteína policlonal
BRPI0813858A2 (pt) Método para produzir peptídeo
BRPI0922710A8 (pt) método para a produção de plaquetas
BRPI0815550A2 (pt) Método para estabilizar fenilefrina
BRPI1007459A2 (pt) método para produção de manômeros olefínicos
BRPI0914680A2 (pt) método para produção de dispositivos de distribuição
BRPI0813960A2 (pt) Processo para produção de biarilas
BRPI0812741A2 (pt) Método para separação de glóbulos
BRPI0918633A2 (pt) método para calcinar matérias-primas.
IL240122A0 (en) A method for producing an antibody
BRPI0909833A2 (pt) método para produção de combustível sintético
BRPI0814011A2 (pt) método para preparação de biobutanol
BRPI0813163A2 (pt) Método para a produção de polissiloxanos cíclicos

Legal Events

Date Code Title Description
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]
B12B Appeal against refusal [chapter 12.2 patent gazette]
B350 Update of information on the portal [chapter 15.35 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 14/10/2008, OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF, QUE DETERMINA A ALTERACAO DO PRAZO DE CONCESSAO.